Intriguingly, expression of GPC1 was also detected in lymph node ESCC metastases, indicating GPC1 may represent a therapeutic target for ESCC with lymph node metastasis (Figure 1C).These data indicate GPC1 may be an attractive therapeutic target for ESCC therapy. This evidence concerns the gene GPC1 and esophageal squamous cell carcinoma.